Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Senile macular degeneration is an older term for age-related macular degeneration (AMD), a disease that damages the macula and affects central vision. It is most common in older adults and usually develops over years. AMD can be dry, with drusen and gradual atrophy, or wet, with abnormal vessels that leak or bleed. Early detection helps guide monitoring and treatment choices that aim to preserve central vision.
read more about senile macular degeneration ...AMD develops from age-related changes in the retinal pigment epithelium and the buildup of drusen under the macula. Genetics can raise risk, and family history plays a strong role in many cases. Smoking is one of the strongest modifiable risk factors and is linked with faster progression. Cardiovascular factors such as high blood pressure and high cholesterol can also contribute for some people. The wet form involves abnormal vessel growth that leaks fluid or blood and can damage the macula more quickly.
Dry AMD often starts with subtle central blur and trouble reading small print, especially in low light. Distortion can develop, and straight lines can look wavy on an Amsler grid. A central gray spot can appear in more advanced disease and can expand over time. Color and contrast sensitivity can drop, which can make faces and fine details harder to see. Wet AMD can cause faster changes, such as sudden distortion, a new dark spot, or rapid central blur in one eye.
A dilated eye exam can show drusen, pigment changes, bleeding, or fluid near the macula. Optical coherence tomography (OCT) is widely used to detect fluid and to track retinal layer changes over time. Fluorescein angiography or OCT angiography can help confirm abnormal vessels in wet AMD. Home monitoring with an Amsler grid can help spot new distortion between visits. Regular exams are recommended for people with risk factors or early AMD in either eye.
Dry AMD care focuses on risk reduction and slowing progression, including stopping smoking and managing blood pressure and cholesterol. AREDS2 vitamin supplements can lower progression risk in intermediate AMD or advanced AMD in one eye, based on clinician guidance. Wet AMD is commonly treated with anti-VEGF injections that reduce leakage and protect central vision. Low-vision tools, better lighting, and reading strategies can help when central vision limits daily tasks. Ongoing monitoring with OCT and symptom checks helps catch new leakage early and guide treatment timing.
Yes. Senile macular degeneration is an older name used before the term age-related macular degeneration became standard. Modern care uses AMD staging and imaging to guide treatment.
Dry AMD involves drusen and gradual macular thinning or atrophy, and it tends to progress more slowly. Wet AMD involves abnormal vessels that leak or bleed and can cause faster central vision loss without treatment.
No, vitamins do not cure AMD. AREDS2 supplements can lower the risk of progression in certain stages, but an eye doctor should confirm that the formula fits the current stage and health history.
Age-Related Macular Degeneration. National Eye Institute. https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/age-related-macular-degeneration. Date Accessed February 4, 2026.
Understanding Macular Degeneration. American Academy of Ophthalmology. https://www.aao.org/eye-health/diseases/amd-macular-degeneration. Date Accessed February 4, 2026.
Age-Related Macular Degeneration. EyeWiki. https://eyewiki.org/Age-Related_Macular_Degeneration. Date Accessed February 4, 2026.
Age-Related Macular Degeneration. American Society of Retina Specialists. https://www.asrs.org/patients/retinal-diseases/2/age-related-macular-degeneration. Date Accessed February 4, 2026.
Age-Related Macular Degeneration: What You Should Know. National Eye Institute. https://www.nei.nih.gov/sites/default/files/2023-02/WhatYouShouldKnow_AMD.pdf. Date Accessed February 4, 2026.